|
|
Post by vissertrades on Nov 21, 2014 14:42:53 GMT -5
He said AFREZZA PK/PD will be VERY helpful and that he was contacted by mail at home regarding AFREZZA. He also said it will come down to insurance acceptance based on price that will make or break uptake. He likes it and can see may possible uses...
|
|
|
|
Post by dreamboatcruise on Nov 21, 2014 15:09:27 GMT -5
I wonder if insurance coverage is still factored in as a "risk" that is reflected in the share price. With how consistently the company has said that it will be priced similarly to injectables, I have been taking most favorable insurance coverage as a given... but perhaps that is me being naive. We know from SNY that pricing pressure is being felt in basal injectables market. Might prandial prices be coming down? Is there a possibility Afrezza does not get favorable treatment? Will price go up if/when this cloud, if it is one, is lifted? Anyone speculate when that might be announced? Have I asked too many questions?
|
|
|
|
Post by bigmoneytex on Nov 21, 2014 17:07:59 GMT -5
if these insurance companies were as smart as they think they are they would make this drug as accessible as possible to the public without throwing up a bunch of BS. The simple fact is that with diabetes the more compliant patients are with treatment the better off they will be in terms of complications. The down the road savings with afrezza are really mind blowing if you stop to think about the cost of diabetes complications are. I hope they don't mess it up.
|
|
|
|
Post by jpg on Nov 21, 2014 18:32:52 GMT -5
I wonder if insurance coverage is still factored in as a "risk" that is reflected in the share price. With how consistently the company has said that it will be priced similarly to injectables, I have been taking most favorable insurance coverage as a given... but perhaps that is me being naive. We know from SNY that pricing pressure is being felt in basal injectables market. Might prandial prices be coming down? Is there a possibility Afrezza does not get favorable treatment? Will price go up if/when this cloud, if it is one, is lifted? Anyone speculate when that might be announced? Have I asked too many questions? Yes. JPG |
|
|
|
Post by vissertrades on Nov 21, 2014 18:34:26 GMT -5
You hit the nail on the head! Sanofi needs to prove this. Net coverage over the patients life to manage this disease should be a benefit to insurance companies.
|
|
|
|
Post by jpg on Nov 21, 2014 18:43:46 GMT -5
Call me living with rose colored glasses but I don't see why insurance companies wouldn't cover this as second line post Metformin? Patients have to take something after failing Metformin. Insulin is easily as good, if not much superior, to everything else pit there. Prandial insulin makes even more sense. Why wuld insurance companies object? I just don't see it being a big medium term problem.
Answer to long?
JPG
|
|
|
|
Post by mrmookie123 on Nov 21, 2014 19:30:13 GMT -5
My wife had a TERRIBLE time with Metformin... Absolutely terrible digestive issues. She was running to the bathroom every
20 minutes, and had terrible Pain. Needless to say, she refuses to take it... Can't blame her, And our Bathroom Smells a lot
better !!
|
|
|
|
Post by babaoriley on Nov 21, 2014 19:49:36 GMT -5
Toooooooo much info, mookie!
|
|
|
|
Post by jpg on Nov 22, 2014 9:52:09 GMT -5
My wife had a TERRIBLE time with Metformin... Absolutely terrible digestive issues. She was running to the bathroom every 20 minutes, and had terrible Pain. Needless to say, she refuses to take it... Can't blame her, And our Bathroom Smells a lot better !! Good point. Metformin certainly doesn't work for everyone. There is a significant group of patients who cannot take it (renal failure being top of the list) or cannot tolerate it (don't know why: we would call it an idiosyncratic reaction). What would be a popular replacement? With time I would speculate Afrezza would be high on the list of replacement drugs for Metformin intolerant patients. JPG |
|
|
|
Post by mrmookie123 on Nov 22, 2014 12:39:54 GMT -5
Just my attempt at Humor, which never seems to work anyway. GLTU.
|
|
|
|
Post by bioexec25 on Nov 22, 2014 15:00:45 GMT -5
That would imply insurance think strategically which historically it's all about minimizing their payments. Plus now with the Obamacare cronies making medical decisions and rationing care who knows what the future holds for emerging drugs and technology.
|
|
|
|
Post by jpg on Nov 22, 2014 17:38:11 GMT -5
That would imply insurance think strategically which historically it's all about minimizing their payments. Plus now with the Obamacare cronies making medical decisions and rationing care who knows what the future holds for emerging drugs and technology. Yes insurance companies think strategically and will pay a bit more to save costs down the line. This is especially true of insurers who have long term relationships with certain groups of patients. Disease management is very popular at pretty much every level of the insurance business. Heart failure, smoking cessation and diabetes ,management are the 3 top topics that I can think of that are a high priority focus for chronic disease management. As for the Obama thing I think that is more political ideology then reality based as far as what is actually happening with insurance mandates before, during and after Obama Care... JPG |
|
